ClinicalTrials.Veeva

Menu

Comparison of Once Daily Versus 8 Hour Dosing of Gentamicin for the Treatment of Intrapartum Chorioamnionitis

Stanford University logo

Stanford University

Status

Completed

Conditions

Chorioamnionitis

Treatments

Drug: gentamicin

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

To compare once daily versus 8 hour dosing of gentamicin for the treatment of chorioamnionitis.

Enrollment

126 estimated patients

Sex

Female

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • clinical diagnosis of chorioamnionitis

Exclusion criteria

  • maternal renal disease, intrauterine fetal death, allergy to gentamicin

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Single Group Assignment

Masking

Triple Blind

126 participants in 2 patient groups

Once daily Gentamicin
Active Comparator group
Treatment:
Drug: gentamicin
Every eight hour Gentamicin
Active Comparator group
Treatment:
Drug: gentamicin

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems